NEOGENE THERAPEUTICS, INC.

Profile

Company Names

NEOGENE THERAPEUTICS, INC.

Addresses

689 FIFTH AVENUE, 12TH FLOOR, NEW YORK, NY 10022

Phone Numbers

212-871-7920

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$125,000,049.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2020-09-02 
$110,000,049.00 
$110,000,049.00 
$0.00 
Equity 
1
2019-05-10 
$15,000,000.00 
$15,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
FEI 
 
CHEN 
DIRECTOR
LAV BRASSICANAPUS, L.P.   |  NEOGENE THERAPEUTICS, INC.
FRANZ 
 
HUMER 
DIRECTOR
ARIX BIOSCIENCE PLC   |  ALLOGENE THERAPEUTICS, INC.   |  NEOGENE THERAPEUTICS, INC.
RAJUL 
 
JAIN 
DIRECTOR
NEOGENE THERAPEUTICS, INC.   |  LB PHARMACEUTICALS INC   |  CAPSTAN THERAPEUTICS, INC.   |  QUANTA THERAPEUTICS, INC.   |  SONOTHERA, INC.
HELEN 
 
KIM 
DIRECTOR
TRINITY BIOSYSTEMS INC   |  NGM BIOPHARMACEUTICALS INC   |  NEOGENE THERAPEUTICS, INC.   |  VIDA VENTURES II, LLC   |  VIDA VENTURES II-A, LLC   |  RECODE THERAPEUTICS, INC.   |  PROTEGO BIOPHARMA   |  PROTEGO BIOPHARMA, INC.
CARSTEN 
 
LINNEMANN, PHD 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
NEOGENE THERAPEUTICS, INC.
RACHEL 
 
MEARS 
DIRECTOR
NEOGENE THERAPEUTICS, INC.
ELISA 
 
PETRIS 
DIRECTOR
NEOGENE THERAPEUTICS, INC.
ANTONIUS 
N.M. 
SCHUMACHER 
DIRECTOR
NEOGENE THERAPEUTICS, INC.
CAROLINE 
 
STOUT 
DIRECTOR
NEOGENE THERAPEUTICS, INC.   |  NEUROGENE INC.   |  AFFINIA THERAPEUTICS INC.   |  NOTCH THERAPEUTICS, INC.
DAVID 
 
TANEN 
DIRECTOR, PROMOTER
NEOGENE THERAPEUTICS, INC.   |  TORREY VIEW, L.L.C.   |  76BIO, INC.
DAVID 
M. 
TANEN 
DIRECTOR, PROMOTER
NILE THERAPEUTICS, INC.   |  ARNO THERAPEUTICS, INC   |  VETERINARY PRIME, INC.   |  ALLOGENE THERAPEUTICS, INC.   |  KRONOS BIO, INC.   |  NEOGENE THERAPEUTICS, INC.   |  ICONOVIR BIO, INC.
KATHERINE 
 
WOOD 
DIRECTOR
ASKLEPIOS BIOPHARMACEUTICAL, INC.   |  CANNES HOLDING PARENT, INC.   |  NEOGENE THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-09-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-02 
2019-05-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-05-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#